Mitotane provided serious side effects and low doses seemed to be tolerated. Determination of mitotane concentration in plasma is recommended. We report the case of toxic plasma levels with low doses of mitotane in a 47-year-old man with adrenocortical cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2515/therapie/2015043 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!